Evidence map›Paper›PMID 28199691›Full record

ArticleThe Journal of infectious diseases2017

Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.

David B Hanna, Juan Lin, Wendy S Post, Howard N Hodis, Xiaonan Xue, Kathryn Anastos, Mardge H Cohen, Stephen J Gange, Sabina A Haberlen, Sonya L Heath and 11 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 1 country.

David B HannaDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Juan LinDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Wendy S PostDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.
Howard N HodisDepartment of Medicine, University of Southern California, Los Angeles.
Xiaonan XueDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Kathryn AnastosDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Mardge H CohenDepartment of Medicine, John H. Stroger, Jr Hospital of Cook County, Chicago, Illinois.
Stephen J GangeDepartment of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
Sabina A HaberlenDepartment of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
Sonya L HeathDepartment of Medicine, University of Alabama at Birmingham.
Jason M LazarDepartment of Medicine, SUNY-Downstate Medical Center, Brooklyn, New York.
Chenglong LiuDepartment of Medicine, Georgetown University Medical Center, Washington, DC.
Wendy J MackDepartment of Preventive Medicine, University of Southern California, Los Angeles.
Igho OfotokunDepartment of Medicine, Emory University and Grady Healthcare System, Atlanta, Georgia.
Frank J PalellaDepartment of Medicine, Northwestern University Medical Center, Chicago, Illinois.
Phyllis C TienDepartment of Medicine, University of California-San Francisco and the Department of Veterans Affairs.
Mallory D WittDepartment of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California.
Alan L LandayDepartment of Immunology and Microbiology, Rush University Medical Center, Chicago, Illinois.
Lawrence A KingsleyDepartments of Epidemiology and Infectious Diseases and Microbiology, University of Pittsburgh, Pennsylvania; and.
Russell P TracyDepartment of Pathology and Laboratory Medicine, University of Vermont, Colchester.
Robert C KaplanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Albert Einstein College of Medicine · USJohns Hopkins University · USUniversity of Southern California · USEmory University · USGeorgetown University Medical Center · USJohn H. Stroger, Jr. Hospital of Cook County · USRush University Medical Center · USSan Francisco VA Medical Center · USSUNY Downstate Health Sciences University · USThe Lundquist Institute · USUniversity Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Pittsburgh · USUniversity of Vermont · US

Funding

MULTICENTER AIDS COHORT STUDYU01AI035039 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 1993 to 2018
$66.4M
Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
Center for the Analysis & Management of the Multicenter AIDS Cohort StudyUM1AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI D'SOUZA, GYPSYAMBER, JACOBSON, LISA P · 2012 to 2018
$20.7M
Role of innate immunity in HIV related vascular disease: biomarkers & mechanismsR01HL126543 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KAPLAN, ROBERT C · 2014 to 2017
$3.7M
NHLBI NIH HHS R01 HL126543NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI034994NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI035039NIAID NIH HHS U01 AI035042NIAID NIH HHS UM1 AI035043
6 · The paper itself

Abstract

Background: Monocytes and monocyte-derived macrophages promote atherosclerosis through increased inflammation and vascular remodeling. This may be especially true in chronic human immunodeficiency virus (HIV) infection. Methods: We examined 778 women (74% HIV+) in the Women's Interagency HIV Study and 503 men (65% HIV+) in the Multicenter AIDS Cohort Study who underwent repeated B-mode carotid artery ultrasound imaging in 2004-2013. We assessed baseline associations of the serum macrophage inflammation markers soluble (s)CD163, sCD14, galectin-3 (Gal-3), and Gal-3 binding protein (Gal-3BP) with carotid plaque formation (focal intima-media thickness >1.5 mm) over 7 years. Results: Marker levels were higher in HIV+ persons versus HIV- persons. Presence of focal plaque increased over time: from 8% to 15% in women, and 24% to 34% in men. After adjustment for demographic, behavioral, and cardiometabolic factors, and CRP and interleukin-6, each standard deviation increase in sCD14 was associated with increased plaque formation (risk ratio [RR] 1.24, 95% confidence interval [CI] 1.07-1.43). This pattern was consistentby sex. sCD163 was associated with plaque formation in virally suppressed HIV+ men (RR 1.52, 95% CI 1.04-2.22); Gal-3BP and Gal-3 were not associated with increased plaque. Conclusions: sCD14 and sCD163 may play important roles in atherogenesis among HIV+ persons.

Indexed as

AdultBiomarkersCarotid Artery DiseasesCarotid Intima-Media ThicknessCohort StudiesDisease ProgressionFemaleGalectin 3HIV InfectionsHumansInflammationLipopolysaccharide ReceptorsMacrophagesMaleMiddle AgedMonocytesBiomarkersGalectin 3Lipopolysaccharide Receptorsatherosclerosisgalectin-3galectin-3 binding proteinHIV infectioninflammationintima-media thicknessmacrophagesmonocytessoluble CD14soluble CD163.

Identifiers

PMID28199691
PMCPMC5722037
OpenAlexW2588956638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.